Association between dipeptidyl peptidase ‐4 inhibitors and increased risk for bullous pemphigoid within 3 months from first use: A 5‐year Population‐Based Cohort Study Using the Japanese National Database

ConclusionsAlthough DPP-4i were associated with increased risk for BP, the risk was particularly significant within 3 months from first use.

Source: Journal of Diabetes Investigation - September 24, 2021 Category: Endocrinology Authors: Hirohito Kuwata, Yuichi Nishioka, Tatsuya Noda, Shinichiro Kubo, Tomoya Myojin, Tsuneyuki Higashino, Yutaka Takahashi, Hitoshi Ishii, Tomoaki Imamura Tags: ORIGINAL ARTICLE Source Type: research